Researchers identify jumping genes that can lead to rare syndrome in children

South Africa News News

Researchers identify jumping genes that can lead to rare syndrome in children
South Africa Latest News,South Africa Headlines
  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 29 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 51%

Researchers identify jumping genes that can lead to rare syndrome in children QMUL NatureSMB

Nature Structural & Molecular Biology

It is a disease that is in desperate need of attention. The mechanism through which MSL3 mutations lead to this syndrome is not known. There is only one previous study which discovered this disease gene, but it is not clear why mutations in MSL3 cause this disorder. Mutations in the MSL3 gene can lead to perturbation of genes involved in development. The developmental genes are intact, but the program that determines how thewill be fine-tuned is impaired. This could lead to a global delay in the development of multiple organs, including the brain.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

medical_xpress /  🏆 101. in UK

South Africa Latest News, South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

CEO of Ground-Breaking DNA Sequencing Company Illumina Resigns Amid Pressure From Investor Carl IcahnCEO of Ground-Breaking DNA Sequencing Company Illumina Resigns Amid Pressure From Investor Carl IcahnNow-former CEO of Illumina Francis deSouza had been locked in a monthslong battle with activist investor Carl Icahn over its $7.1 billion acquisition of cancer test maker Grail.
Read more »

Dangerous weight loss trend triggers Iatrogenic botulism outbreak in EuropeDangerous weight loss trend triggers Iatrogenic botulism outbreak in EuropeDangerous weight loss trend triggers Iatrogenic botulism outbreak in Europe Botulism Neurotoxin ClostridiumBotulinum IatrogenicBotulism MedicalRisk CosmeticComplications Eurosurveillanc
Read more »

Scientists use machine learning to unveil new predictors of post-menopausal breast cancerScientists use machine learning to unveil new predictors of post-menopausal breast cancerScientists use machine learning to unveil new predictors of post-menopausal breast cancer BreastCancer Predictors PostMenopausal Health PolygenicRisk MachineLearning Medicine RiskPrediction StatisticalModels CancerResearch SciReports
Read more »

Christie Brinkley and her daughters look like sisters in breathtaking new photoshootChristie Brinkley and her daughters look like sisters in breathtaking new photoshootThe iconic model has passed on her strong genes
Read more »

SVcnn: an accurate deep learning-based method for detecting structural variation based on long-read data - BMC BioinformaticsSVcnn: an accurate deep learning-based method for detecting structural variation based on long-read data - BMC BioinformaticsBackground Structural variations (SVs) refer to variations in an organism’s chromosome structure that exceed a length of 50 base pairs. They play a significant role in genetic diseases and evolutionary mechanisms. While long-read sequencing technology has led to the development of numerous SV caller methods, their performance results have been suboptimal. Researchers have observed that current SV callers often miss true SVs and generate many false SVs, especially in repetitive regions and areas with multi-allelic SVs. These errors are due to the messy alignments of long-read data, which are affected by their high error rate. Therefore, there is a need for a more accurate SV caller method. Result We propose a new method-SVcnn, a more accurate deep learning-based method for detecting SVs by using long-read sequencing data. We run SVcnn and other SV callers in three real datasets and find that SVcnn improves the F1-score by 2–8% compared with the second-best method when the read depth is greater than 5×. More importantly, SVcnn has better performance for detecting multi-allelic SVs. Conclusions SVcnn is an accurate deep learning-based method to detect SVs. The program is available at https://github.com/nwpuzhengyan/SVcnn .
Read more »

Neuroinflammation in Alzheimer’s disease: microglial signature and their relevance to disease - Inflammation and RegenerationNeuroinflammation in Alzheimer’s disease: microglial signature and their relevance to disease - Inflammation and RegenerationAlzheimer’s disease (AD) is the most common form of dementia, pathologically characterized by senile plaques and neurofibrillary tangles (NFTs), resulting in neurodegeneration. Neuroinflammation, defined as the activation of glial cells such as microglia and astrocytes, is observed surrounding senile plaques and affected neurons in AD. Recently conducted genome-wide association studies (GWAS) indicate that a large section of identified AD risk genes are involved in immune responses and are enriched in microglia. Microglia are innate immune cells in the central nervous system (CNS), which are involved in immune surveillance and maintenance of homeostasis in the CNS. Recently, a novel subpopulation of activated microglia named as disease-associated microglia (DAM), also known as activated response microglia (ARM) or microglial neurodegenerative phenotype (MGnD), was identified in AD model mice. These microglia closely associate with β-amyloid (Aβ) plaques and exhibit characteristic gene expression profiles accompanied with reduced expressions of homeostatic microglial genes. However, it remains unclear whether decreased homeostatic microglia functions or increased DAM/ARM/MGnD functions correlate with the degree of neuronal loss in AD. To translate the results of rodent studies to human AD, precuneus, the brain region vulnerable to β-amyloid accumulation in preclinical AD, is of high interest, as it can provide novel insights into the mechanisms of microglia response to Aβ in early AD. In this study, we performed comparative analyses of gene expression profiles of microglia among three representative neurodegenerative mouse models and the human precunei with early AD pathology. We proceeded to evaluate the identified genes as potential therapeutic targets for AD. We believe that our findings will provide important resources to better understand the role of glial dysfunction in AD.
Read more »



Render Time: 2025-03-06 19:43:51